{"key":"op_800_DE","page":{"url":"https://pt.bookimed.com/clinics/country=germany/procedure=car-t-cell-therapy/","procedure":{"id":800,"slug":"car-t-cell-therapy","name":"Terapia com células T CAR","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"hematology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":22,"iso":"DE","name":"Alemanha"},"currency":"USD","data_date":"2026-11-01"},"pages":{"clinics_url":"https://pt.bookimed.com/clinics/country=germany/procedure=car-t-cell-therapy/","cost_url":"https://pt.bookimed.com/clinics/country=germany/procedure=car-t-cell-therapy/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":285000,"to":365000,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":420000,"to":540000},"uk":{"from":330000,"to":420000},"by_technique":[{"technique":"Autologous CD19-directed CAR T-cell therapy","technique_id":"autologous-cd19-directed-car","price_from":285000,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"Autologous BCMA-directed CAR T-cell therapy","technique_id":"autologous-bcma-directed-car","price_from":345000,"currency":"USD","source":"estimate","date":"2026-11-17"}],"by_city":[{"city":"Nuremberga","from":285000},{"city":"Frankfurt am Main","from":285000},{"city":"Berlim","from":230000}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":90000,"to":150000},{"country_iso":"FR","from":295000,"to":385000},{"country_iso":"GB","from":330000,"to":420000},{"country_iso":"US","from":420000,"to":540000},{"country_iso":"IL","from":84000,"to":405000},{"country_iso":"TR","from":150000,"to":220000},{"country_iso":"MX","from":120000,"to":185000},{"country_iso":"CA","from":340000,"to":470000},{"country_iso":"AE","from":190000,"to":310000},{"country_iso":"TH","from":150000,"to":220000},{"country_iso":"PL","from":165000,"to":230000},{"country_iso":"KR","from":220000,"to":300000},{"country_iso":"CZ","from":150000,"to":195000},{"country_iso":"AT","from":280000,"to":365000},{"country_iso":"ES","from":380000,"to":520000},{"country_iso":"IT","from":400000,"to":650000},{"country_iso":"CN","from":275000,"to":310000},{"country_iso":"AU","from":330000,"to":420000},{"country_iso":"IN","from":38000,"to":70000},{"country_iso":"MY","from":120000,"to":180000},{"country_iso":"VN","from":150000,"to":230000},{"country_iso":"BR","from":280000,"to":400000}],"base_country":"US","base_is_fallback":false},"savings":{"pct":32,"variant":">=15%"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":2,"items":[{"id":136,"name":"Nordwest Clinic (Krankenhaus)","city":"Frankfurt am Main","rating":4.5,"reviews_count":57,"accreditations":["TÜV AG Сompany Research & Investing Certificate","TOP German hospital according to 2019 Focus ranking","World's Best Hospitals 2021 by Newsweek"],"rank":1,"has_procedure":true,"why_ranked":"Offers personalized CAR T-cell therapy programs with detailed preparatory consultations. ESMO-certified oncology center, ranked among top German hospitals for cancer treatment effectiveness.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":241,"name":"Dr. Radu + Partner Aesthetic and Plastic Surgery - Nuremberg","city":"Nuernberg","rating":{"status":"missing","reason":"not_collected"},"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":{"status":"missing","reason":"not_collected"},"rank":2,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":{"status":"missing","reason":"not_collected"},"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":332,"slug":"nuernberg","name":"Nuremberga","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":285000,"profile":{"city_type":"Second-largest city in Bavaria, Germany","access":["Nuremberg Airport (NUE), 5 km from the city center"],"sources":["https://en.wikipedia.org/wiki/Nuremberg","https://en.wikipedia.org/wiki/Nuremberg_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":354,"slug":"frankfurt-am-main","name":"Frankfurt am Main","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":285000,"profile":{"city_type":"Most populous city in Hesse, Germany","access":["Frankfurt Airport (FRA), 12 km from the city center"],"sources":["https://en.wikipedia.org/wiki/Frankfurt","https://en.wikipedia.org/wiki/Frankfurt_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":23,"slug":"berlin","name":"Berlim","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":230000,"profile":{"city_type":"Capital and largest city of Germany","access":["Berlin Airport (BER), 18 km from the city center"],"sources":["https://en.wikipedia.org/wiki/Berlin","https://en.wikipedia.org/wiki/Berlin_Brandenburg_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["Relapsed or refractory large B-cell lymphoma","Relapsed or refractory B-cell acute lymphoblastic leukemia","Relapsed or refractory follicular and mantle cell lymphoma","Relapsed or refractory multiple myeloma (BCMA-directed)","Relapsed or refractory chronic lymphocytic leukemia"],"contraindications":["Active uncontrolled infection, including uncontrolled hepatitis B/C or HIV","Significant cardiac, pulmonary, renal or hepatic dysfunction","Active CNS or autoimmune neurological disease (relative, product-dependent)","Poor performance status or rapid progression during manufacturing (relative)","Severe hypersensitivity to DMSO or product excipients","Pregnancy or breastfeeding","Active uncontrolled graft-versus-host disease (relative, prior transplant)"],"operation_hours":{"min":0.5,"max":1,"unit":"hours","qualifier":"Duration of the single CAR T-cell infusion itself; leukapheresis (about 3-6 hours) and lymphodepletion are separate."},"anesthesia":["none"],"sessions_or_stages":{"sessions":{"min":1,"max":1,"unit":"visits","qualifier":"One CAR T-cell infusion; leukapheresis and lymphodepletion are preceding stages."},"stages":[{"code":"leukapheresis","label":"Leukapheresis to collect T cells","after":{"min":0,"max":0,"unit":"days","qualifier":"Starting point of the treatment pathway"}},{"code":"lymphodepletion","label":"Lymphodepleting chemotherapy","after":{"min":23,"max":58,"unit":"days","qualifier":"About 3-8 weeks after leukapheresis; 2-5 days before infusion"}},{"code":"car_t_infusion","label":"CAR T-cell infusion","after":{"min":28,"max":63,"unit":"days","qualifier":"Depends on manufacturing and product release time"}}],"qualifier":"Single-infusion therapy; timelines vary by product and center."},"hospital_nights":{"value":{"min":10,"max":21,"unit":"nights","qualifier":"Inpatient stay with daily CRS/ICANS monitoring, about 2 weeks; longer if ICU needed."},"source":"parsed_details"},"treatment_conditions":["inpatient"],"rehabilitation_days":{"min":60,"max":90,"unit":"days","qualifier":"Functional recovery after the 4-week monitoring period; slower with persistent fatigue, cytopenias, neurotoxicity or infections."},"fly_home_after_days":{"min":28,"max":42,"unit":"days","qualifier":"Stay near the centre at least 4 weeks, past peak CRS/ICANS risk. Fly if no toxicity, counts acceptable."},"back_to_work_days":{"min":60,"max":90,"unit":"days","qualifier":"Desk work usually resumes at 2–3 months, once CRS/ICANS risk and cytopenias settle. Later if fatigue, neurotoxicity or infections persist."},"exercise_resume_weeks":{"min":8,"max":12,"unit":"weeks","qualifier":"Strenuous exercise waits about 2–3 months, until counts recover and early neurotoxicity and infection risk passes. Light walking earlier."},"final_result_months":{"min":1,"max":3,"unit":"months","qualifier":"Response is assessed at about 1 month and 3 months after infusion; remission durability needs longer follow-up."},"result_longevity":"In large B-cell lymphoma, about 40% remain progression-free at 1 year; some stay in long-term remission. In B-ALL, about 36% relapse; CAR T cells can persist up to about 5 years.","main_risks":["Cytokine release syndrome","Immune effector cell-associated neurotoxicity syndrome","Prolonged cytopenias","Infections and hypogammaglobulinemia","B-cell aplasia","Hemophagocytic lymphohistiocytic-like syndrome","Secondary T-cell malignancies (rare)","Tumor lysis syndrome","Infusion-related hypersensitivity reactions"],"complication_rate_pct":{"min":50,"max":95,"unit":"percent","qualifier":"Any-grade cytokine release syndrome or neurotoxicity within about 8 weeks; severe grade 3+ events roughly 10-25%."},"revision_rate_pct":{"status":"missing","reason":"not_collected"},"success":{"metric":"Complete response rate in relapsed/refractory large B-cell lymphoma (3rd-line or later)","value":51,"horizon":"Best response, typically assessed at 1-3 months after infusion","source":{"status":"missing","reason":"not_collected"},"evidence_status":"limited"},"scars":"There is no surgical incision, only small puncture marks from the leukapheresis or central venous line sites.","pain":"The infusion itself is generally painless; fever, headache, body aches and malaise may occur with cytokine release, and leukapheresis involves line placement with mild discomfort.","preparation":["Specialist eligibility assessment and disease staging","Infection screening and organ function evaluation","Leukapheresis to collect the patient's T cells","Possible bridging therapy while the cells are manufactured (weeks)","Lymphodepleting chemotherapy a few days before infusion","Central venous access as needed","Arrange nearby accommodation and a caregiver after infusion","Confirm target antigen (e.g., CD19, BCMA) and prior-therapy eligibility","Pre-infusion premedication (paracetamol and antihistamine)","Access to tocilizumab and ICU-level support before infusion"],"recovery_timeline":[{"phase":"Infusion and first 1-2 weeks","description":"Single IV infusion followed by close monitoring for cytokine release syndrome and neurotoxicity, usually peaking in the first 1-2 weeks.","restrictions":["Stay near the treatment center"]},{"phase":"Weeks 2-4","description":"Discharge when stable, frequent visits, blood count and infection monitoring, first response assessment around day 28.","restrictions":["Stay near the treatment center until about day 28","No driving for at least 8 weeks","Avoid crowds and infection exposure"]},{"phase":"Months 2-12","description":"Gradual recovery of blood counts and energy, immune function monitoring, immunoglobulin replacement if needed, response reassessment.","restrictions":["Delay live vaccines per specialist advice"]}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":7,"max":14,"unit":"days","qualifier":"Frequent early monitoring for cytokine release syndrome and neurotoxicity if discharged"}},{"purpose":"result_review","requirement":"routine","after":{"min":28,"max":35,"unit":"days","qualifier":"First response assessment, about day 28-35 after infusion"}},{"purpose":"result_review","requirement":"routine","after":{"min":85,"max":100,"unit":"days","qualifier":"Response reassessment about day 85-100 (around 3 months) after infusion"}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Ask the clinic for examples of the practitioners' experience with the exact procedure you are planning","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Ask for examples of the practitioners’ experience with the surgery you are intending to have.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C2","text":"Ask whether a doctor is always present in the clinic and whether a high dependency or intensive care unit exists","scope":"treatment_abroad","source":{"url":"https://www.bapras.org.uk/public/patient-information/cosmetic-surgery/cosmetic-surgery-abroad","host":"bapras.org.uk","quote":"Is there always a doctor in the clinic and is there a high dependency or intensive care unit?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C3","text":"Confirm the surgeon is trained and experienced in the exact procedure you are considering, not just in surgery generally","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Verify that the surgeon is trained and experienced in performing the procedure you are considering.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C4","text":"Check that the surgeon who consults with you is the same person who will carry out the procedure","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Check that the surgeon you consult with, will be the same person carrying out the procedure.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C5","text":"Decide before you travel where check-ups after the operation will take place, because follow-up abroad may be missing or weaker","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You need to think about where check-ups will take place.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Pressure to decide quickly, or cheap time-limited offers, is a warning sign of a clinic offer","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F2","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Confusion or difficulty communicating","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-immunotherapy-investigating-side-effects","host":"cancer.gov","quote":"Patients also may experience neurologic symptoms such as confusion, tremors, or difficulty communicating.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W2","text":"Excessive sleepiness","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/research/car-t-cells","host":"cancer.gov","quote":"Some of the hallmark signs of ICANS include confusion, excessive sleepiness, and impaired speech.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W3","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/flu-symptoms","host":"cancer.gov","quote":"Immunotherapy treatments such as CAR T-cell therapy and some monoclonal antibodies may cause cytokine release syndrome (CRS), a condition that can lead to severe flu-like symptoms as well as a rash, rapid heartbeat, low blood pressure, and trouble breathing.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W4","text":"Fever","urgency":"contact_clinic","general":true,"source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-immunotherapy-investigating-side-effects","host":"cancer.gov","quote":"Many patients who receive CAR T-cell therapy develop a condition known as cytokine release syndrome, which can cause a fever, fast heart rate, low blood pressure, and rash, among other symptoms.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Shows emergency staff and other doctors the patient is a CAR T recipient","document":"car t wallet card","source":{"url":"https://www.mskcc.org/cancer-care/patient-education/car-cell-therapy-guide-adult-patients-caregivers","host":"mskcc.org","quote":"Carry your wallet card with you at all times.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T2","text":"Home doctor needs the plan the treating team set for leaving hospital","document":"written discharge instructions","source":{"url":"https://www.mskcc.org/cancer-care/patient-education/car-cell-therapy-guide-adult-patients-caregivers","host":"mskcc.org","quote":"Your CAR T team will give you discharge instructions before you leave the hospital.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T3","text":"Home doctor needs the exact medicines to continue treatment safely","document":"discharge medicines list","source":{"url":"https://www.cuh.nhs.uk/patient-information/discharge-advice-from-ward-c10c9-following-car-t-cell-therapy/","host":"cuh.nhs.uk","quote":"You will be given a copy of all the medications that you should take after being discharged.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Complete blood count","aliases":["Complete blood count","CBC","Full blood count"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Recent CBC, kidney and liver function tests"},{"field":"packages","text":"Complete blood count with cancer markers and a proteinogram"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Biopsy","aliases":["Biopsy","Bone marrow biopsy"],"kind":"other","origin":[{"field":"initial_assessment_documents","text":"Bone marrow biopsy report"},{"field":"packages","text":"Biopsy"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"PET-CT scan","aliases":["PET-CT scan","PET-CT","PET/CT"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent PET-CT or MRI report"},{"field":"packages","text":"PET/CT"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"MRI scan","aliases":["MRI scan","MRI","Head MRI"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent PET-CT or MRI report"},{"field":"packages","text":"Head MRI"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Echocardiogram","aliases":["Echocardiogram","Echocardiography"],"kind":"heart","origin":[{"field":"initial_assessment_documents","text":"Echocardiogram report (if available)"},{"field":"packages","text":"Echocardiography"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Kidney function test","aliases":["Kidney function test","Kidney function tests"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Recent CBC, kidney and liver function tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"Liver function test","aliases":["Liver function test","Liver function tests"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Recent CBC, kidney and liver function tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"Blood tests","aliases":["Blood tests"],"kind":"lab","origin":[{"field":"packages","text":"Blood tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T9","name":"Tumor marker test","aliases":["Tumor marker test","Cancer markers"],"kind":"lab","origin":[{"field":"packages","text":"Complete blood count with cancer markers and a proteinogram"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T10","name":"Serum protein electrophoresis","aliases":["Serum protein electrophoresis","Proteinogram"],"kind":"lab","origin":[{"field":"packages","text":"Complete blood count with cancer markers and a proteinogram"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":1},"prep_in_advance":{"status":"ok","items":[{"id":"P1","action":"Ask your team whether chemotherapy or radiation will be given before the T cells are returned to you","why":"The treatment aims to get rid of other immune cells","who_decides":"prescriber","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-therapy","host":"cancer.gov","quote":"During this time, you may have treatment with chemotherapy and, maybe, radiation therapy to get rid of other immune cells.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":1},"visit_and_day":{"status":"ok","has_procedure_day":true,"items":[{"id":"V1","text":"The CAR T-cell product is sent back to the hospital and returned to the patient as a single infusion","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/research/car-t-cells","host":"cancer.gov","quote":"These expanded cells are the final CAR T-cell therapy product, which is sent back to the hospital to be returned to the patient as a single infusion.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},{"id":"V2","text":"The T cells grown in the lab are given back to the patient through a needle in a vein","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-therapy","host":"cancer.gov","quote":"After these treatments, the T cells that were grown in the lab will be given back to you via a needle in your vein.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":1},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":60,"max":90,"unit":"days","qualifier":"Desk work usually resumes at 2–3 months, once CRS/ICANS risk and cytopenias settle. Later if fatigue, neurotoxicity or infections persist."},"complication_rate_pct":{"min":50,"max":95,"unit":"percent","qualifier":"Any-grade cytokine release syndrome or neurotoxicity within about 8 weeks; severe grade 3+ events roughly 10-25%."},"contraindications":["Active uncontrolled infection, including uncontrolled hepatitis B/C or HIV","Significant cardiac, pulmonary, renal or hepatic dysfunction","Active CNS or autoimmune neurological disease (relative, product-dependent)","Poor performance status or rapid progression during manufacturing (relative)","Severe hypersensitivity to DMSO or product excipients","Pregnancy or breastfeeding","Active uncontrolled graft-versus-host disease (relative, prior transplant)"],"days_in_clinic":{"min":10,"max":21,"unit":"nights","qualifier":"Inpatient stay with daily CRS/ICANS monitoring, about 2 weeks; longer if ICU needed."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":8,"max":12,"unit":"weeks","qualifier":"Strenuous exercise waits about 2–3 months, until counts recover and early neurotoxicity and infection risk passes. Light walking earlier."},"final_result_months":{"min":1,"max":3,"unit":"months","qualifier":"Response is assessed at about 1 month and 3 months after infusion; remission durability needs longer follow-up."},"fly_home_after_days":{"min":28,"max":42,"unit":"days","qualifier":"Stay near the centre at least 4 weeks, past peak CRS/ICANS risk. Fly if no toxicity, counts acceptable."},"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":7,"max":14,"unit":"days","qualifier":"Frequent early monitoring for cytokine release syndrome and neurotoxicity if discharged"}},{"purpose":"result_review","requirement":"routine","after":{"min":28,"max":35,"unit":"days","qualifier":"First response assessment, about day 28-35 after infusion"}},{"purpose":"result_review","requirement":"routine","after":{"min":85,"max":100,"unit":"days","qualifier":"Response reassessment about day 85-100 (around 3 months) after infusion"}}],"indications":["Relapsed or refractory large B-cell lymphoma","Relapsed or refractory B-cell acute lymphoblastic leukemia","Relapsed or refractory follicular and mantle cell lymphoma","Relapsed or refractory multiple myeloma (BCMA-directed)","Relapsed or refractory chronic lymphocytic leukemia"],"main_risks":["Cytokine release syndrome","Immune effector cell-associated neurotoxicity syndrome","Prolonged cytopenias","Infections and hypogammaglobulinemia","B-cell aplasia","Hemophagocytic lymphohistiocytic-like syndrome","Secondary T-cell malignancies (rare)","Tumor lysis syndrome","Infusion-related hypersensitivity reactions"],"pain":"The infusion itself is generally painless; fever, headache, body aches and malaise may occur with cytokine release, and leukapheresis involves line placement with mild discomfort.","preparation":["Specialist eligibility assessment and disease staging","Infection screening and organ function evaluation","Leukapheresis to collect the patient's T cells","Possible bridging therapy while the cells are manufactured (weeks)","Lymphodepleting chemotherapy a few days before infusion","Central venous access as needed","Arrange nearby accommodation and a caregiver after infusion","Confirm target antigen (e.g., CD19, BCMA) and prior-therapy eligibility","Pre-infusion premedication (paracetamol and antihistamine)","Access to tocilizumab and ICU-level support before infusion"],"recovery_timeline":[{"phase":"Infusion and first 1-2 weeks","description":"Single IV infusion followed by close monitoring for cytokine release syndrome and neurotoxicity, usually peaking in the first 1-2 weeks.","restrictions":["Stay near the treatment center"]},{"phase":"Weeks 2-4","description":"Discharge when stable, frequent visits, blood count and infection monitoring, first response assessment around day 28.","restrictions":["Stay near the treatment center until about day 28","No driving for at least 8 weeks","Avoid crowds and infection exposure"]},{"phase":"Months 2-12","description":"Gradual recovery of blood counts and energy, immune function monitoring, immunoglobulin replacement if needed, response reassessment.","restrictions":["Delay live vaccines per specialist advice"]}],"rehabilitation_days":{"min":60,"max":90,"unit":"days","qualifier":"Functional recovery after the 4-week monitoring period; slower with persistent fatigue, cytopenias, neurotoxicity or infections."},"result_longevity":"In large B-cell lymphoma, about 40% remain progression-free at 1 year; some stay in long-term remission. In B-ALL, about 36% relapse; CAR T cells can persist up to about 5 years.","revision_rate_pct":null,"scars":"There is no surgical incision, only small puncture marks from the leukapheresis or central venous line sites.","sessions_or_stages":{"sessions":{"min":1,"max":1,"unit":"visits","qualifier":"One CAR T-cell infusion; leukapheresis and lymphodepletion are preceding stages."},"stages":[{"code":"leukapheresis","label":"Leukapheresis to collect T cells","after":{"min":0,"max":0,"unit":"days","qualifier":"Starting point of the treatment pathway"}},{"code":"lymphodepletion","label":"Lymphodepleting chemotherapy","after":{"min":23,"max":58,"unit":"days","qualifier":"About 3-8 weeks after leukapheresis; 2-5 days before infusion"}},{"code":"car_t_infusion","label":"CAR T-cell infusion","after":{"min":28,"max":63,"unit":"days","qualifier":"Depends on manufacturing and product release time"}}],"qualifier":"Single-infusion therapy; timelines vary by product and center."},"success":{"metric":"Complete response rate in relapsed/refractory large B-cell lymphoma (3rd-line or later)","value":51,"unit":"percent","horizon":"Best response, typically assessed at 1-3 months after infusion","evidence_status":"limited","population":"Adults with relapsed/refractory LBCL after two or more prior lines"},"techniques":[{"name":"Autologous CD19-directed CAR T-cell therapy","suits_whom":"Relapsed/refractory B-cell lymphomas and B-ALL","recovery":"Inpatient monitoring about 10-21 days, then nearby follow-up to day 28."},{"name":"Autologous BCMA-directed CAR T-cell therapy","suits_whom":"Relapsed/refractory multiple myeloma after multiple prior lines","recovery":"Similar monitoring; prolonged cytopenias are common."}],"treatment_conditions":["inpatient"],"treatment_duration_hours":{"min":0.5,"max":1,"unit":"hours","qualifier":"Duration of the single CAR T-cell infusion itself; leukapheresis (about 3-6 hours) and lymphodepletion are separate."},"initial_assessment_documents":["Pathology report with CD19 or BCMA status","Summary of prior treatment lines and responses","Recent PET-CT or MRI report","Bone marrow biopsy report","Recent CBC, kidney and liver function tests","Echocardiogram report (if available)"],"travel_trips":{"min":1,"max":2,"one_trip_possible":true,"qualifier":"Cell collection, then 3-9 weeks manufacturing, usually at home; return for infusion and 4+ weeks nearby. One trip means staying."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Ask the clinic for examples of the practitioners' experience with the exact procedure you are planning","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Ask for examples of the practitioners’ experience with the surgery you are intending to have.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C2","text":"Ask whether a doctor is always present in the clinic and whether a high dependency or intensive care unit exists","scope":"treatment_abroad","source":{"url":"https://www.bapras.org.uk/public/patient-information/cosmetic-surgery/cosmetic-surgery-abroad","host":"bapras.org.uk","quote":"Is there always a doctor in the clinic and is there a high dependency or intensive care unit?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C3","text":"Confirm the surgeon is trained and experienced in the exact procedure you are considering, not just in surgery generally","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Verify that the surgeon is trained and experienced in performing the procedure you are considering.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C4","text":"Check that the surgeon who consults with you is the same person who will carry out the procedure","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Check that the surgeon you consult with, will be the same person carrying out the procedure.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C5","text":"Decide before you travel where check-ups after the operation will take place, because follow-up abroad may be missing or weaker","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You need to think about where check-ups will take place.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Pressure to decide quickly, or cheap time-limited offers, is a warning sign of a clinic offer","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F2","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Confusion or difficulty communicating","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-immunotherapy-investigating-side-effects","host":"cancer.gov","quote":"Patients also may experience neurologic symptoms such as confusion, tremors, or difficulty communicating.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W2","text":"Excessive sleepiness","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/research/car-t-cells","host":"cancer.gov","quote":"Some of the hallmark signs of ICANS include confusion, excessive sleepiness, and impaired speech.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W3","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/flu-symptoms","host":"cancer.gov","quote":"Immunotherapy treatments such as CAR T-cell therapy and some monoclonal antibodies may cause cytokine release syndrome (CRS), a condition that can lead to severe flu-like symptoms as well as a rash, rapid heartbeat, low blood pressure, and trouble breathing.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W4","text":"Fever","urgency":"contact_clinic","general":true,"source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-immunotherapy-investigating-side-effects","host":"cancer.gov","quote":"Many patients who receive CAR T-cell therapy develop a condition known as cytokine release syndrome, which can cause a fever, fast heart rate, low blood pressure, and rash, among other symptoms.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Shows emergency staff and other doctors the patient is a CAR T recipient","document":"car t wallet card","source":{"url":"https://www.mskcc.org/cancer-care/patient-education/car-cell-therapy-guide-adult-patients-caregivers","host":"mskcc.org","quote":"Carry your wallet card with you at all times.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T2","text":"Home doctor needs the plan the treating team set for leaving hospital","document":"written discharge instructions","source":{"url":"https://www.mskcc.org/cancer-care/patient-education/car-cell-therapy-guide-adult-patients-caregivers","host":"mskcc.org","quote":"Your CAR T team will give you discharge instructions before you leave the hospital.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T3","text":"Home doctor needs the exact medicines to continue treatment safely","document":"discharge medicines list","source":{"url":"https://www.cuh.nhs.uk/patient-information/discharge-advice-from-ward-c10c9-following-car-t-cell-therapy/","host":"cuh.nhs.uk","quote":"You will be given a copy of all the medications that you should take after being discharged.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"You are older and not eligible for CAR T-cell therapy","name":"Bispecific antibody therapy","source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2022/tecvayli-multiple-myeloma","host":"cancer.gov","quote":"with bispecific antibodies you'll be able to treat older patients who are not eligible for CAR T-cell therapies","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":null}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"technique_details":{"status":"ok","items":[{"id":"autologous-cd19-directed-car","name":"Autologous CD19-directed CAR T-cell therapy","how_it_works":{"text":"Modified T cells recognize an antigen on cancer cells","source":{"url":"https://www.leedsth.nhs.uk/?p=50458","host":"leedsth.nhs.uk","quote":"These new receptors will enable the T-cells to recognise and attach to the antigen on the cancer cell.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"autologous-bcma-directed-car","name":"Autologous BCMA-directed CAR T-cell therapy","how_it_works":{"text":"Engineered cells are designed to recognize BCMA, a protein on myeloma cells","source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2021/fda-ide-cel-car-t-multiple-myeloma","host":"cancer.gov","quote":"genetic engineering lets the CAR T cells \"see\" BCMA, a protein that's present at high amounts in multiple myeloma cells","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Complete blood count","aliases":["Complete blood count","CBC","Full blood count"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Recent CBC, kidney and liver function tests"},{"field":"packages","text":"Complete blood count with cancer markers and a proteinogram"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Biopsy","aliases":["Biopsy","Bone marrow biopsy"],"kind":"other","origin":[{"field":"initial_assessment_documents","text":"Bone marrow biopsy report"},{"field":"packages","text":"Biopsy"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"PET-CT scan","aliases":["PET-CT scan","PET-CT","PET/CT"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent PET-CT or MRI report"},{"field":"packages","text":"PET/CT"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"MRI scan","aliases":["MRI scan","MRI","Head MRI"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent PET-CT or MRI report"},{"field":"packages","text":"Head MRI"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Echocardiogram","aliases":["Echocardiogram","Echocardiography"],"kind":"heart","origin":[{"field":"initial_assessment_documents","text":"Echocardiogram report (if available)"},{"field":"packages","text":"Echocardiography"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Kidney function test","aliases":["Kidney function test","Kidney function tests"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Recent CBC, kidney and liver function tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"Liver function test","aliases":["Liver function test","Liver function tests"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Recent CBC, kidney and liver function tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"Blood tests","aliases":["Blood tests"],"kind":"lab","origin":[{"field":"packages","text":"Blood tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T9","name":"Tumor marker test","aliases":["Tumor marker test","Cancer markers"],"kind":"lab","origin":[{"field":"packages","text":"Complete blood count with cancer markers and a proteinogram"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T10","name":"Serum protein electrophoresis","aliases":["Serum protein electrophoresis","Proteinogram"],"kind":"lab","origin":[{"field":"packages","text":"Complete blood count with cancer markers and a proteinogram"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":1},"prep_in_advance":{"status":"ok","items":[{"id":"P1","action":"Ask your team whether chemotherapy or radiation will be given before the T cells are returned to you","why":"The treatment aims to get rid of other immune cells","who_decides":"prescriber","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-therapy","host":"cancer.gov","quote":"During this time, you may have treatment with chemotherapy and, maybe, radiation therapy to get rid of other immune cells.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":1},"visit_and_day":{"status":"ok","has_procedure_day":true,"items":[{"id":"V1","text":"The CAR T-cell product is sent back to the hospital and returned to the patient as a single infusion","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/research/car-t-cells","host":"cancer.gov","quote":"These expanded cells are the final CAR T-cell therapy product, which is sent back to the hospital to be returned to the patient as a single infusion.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},{"id":"V2","text":"The T cells grown in the lab are given back to the patient through a needle in a vein","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-therapy","host":"cancer.gov","quote":"After these treatments, the T cells that were grown in the lab will be given back to you via a needle in your vein.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":1},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"}}},"techniques":[{"id":"autologous-cd19-directed-car","name":"Autologous CD19-directed CAR T-cell therapy","how_it_works":{"id":"H1","text":"Modified T cells recognize an antigen on cancer cells","source":{"url":"https://www.leedsth.nhs.uk/?p=50458","host":"leedsth.nhs.uk","quote":"These new receptors will enable the T-cells to recognise and attach to the antigen on the cancer cell.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Relapsed/refractory B-cell lymphomas and B-ALL","price_from":285000,"recovery":"Inpatient monitoring about 10-21 days, then nearby follow-up to day 28."},{"id":"autologous-bcma-directed-car","name":"Autologous BCMA-directed CAR T-cell therapy","how_it_works":{"id":"H1","text":"Engineered cells are designed to recognize BCMA, a protein on myeloma cells","source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2021/fda-ide-cel-car-t-multiple-myeloma","host":"cancer.gov","quote":"genetic engineering lets the CAR T cells \"see\" BCMA, a protein that's present at high amounts in multiple myeloma cells","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Relapsed/refractory multiple myeloma after multiple prior lines","price_from":345000,"recovery":"Similar monitoring; prolonged cytopenias are common."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"You are older and not eligible for CAR T-cell therapy","name":"Bispecific antibody therapy","source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2022/tecvayli-multiple-myeloma","host":"cancer.gov","quote":"with bispecific antibodies you'll be able to treat older patients who are not eligible for CAR T-cell therapies","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":null}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-11","next_check_at":"2027-02-09"},"travel":{"status":"ok","items":[{"id":"V1","item":"visa","audience":"uk","volatile":true,"text":"British passport holders can travel to the Schengen area, which includes Germany, without a visa for up to 90 days in any 180-day period","source":{"url":"https://www.gov.uk/foreign-travel-advice/germany/entry-requirements","host":"gov.uk","quote":"You can travel without a visa to the Schengen area , which includes Germany, for up to 90 days in any 180-day period.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"passport_validity","audience":"uk","volatile":true,"text":"A UK passport must have an expiry date at least 3 months after the day you plan to leave the Schengen area","source":{"url":"https://www.gov.uk/foreign-travel-advice/germany/entry-requirements","host":"gov.uk","quote":"have an ‘expiry date’ at least 3 months after the day you plan to leave the Schengen area (the expiry date does not need to be within 10 years of the date of issue)","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V3","item":"passport_validity","audience":"us","volatile":true,"text":"A US passport should be valid for at least 3 months beyond your period of stay when transiting a Schengen country","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Germany.html","host":"travel.state.gov","quote":"Your passport should be valid for at least 3 months beyond your period of stay if you plan on transiting a Schengen country.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V4","item":"medicines","audience":"all","volatile":false,"text":"For medications Germany classifies as narcotics, you may only carry a 30-day supply","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Germany.html","host":"travel.state.gov","quote":"For medications that Germany classifies as narcotics, you may only carry a 30-day supply.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V5","item":"ghic","audience":"uk","volatile":false,"text":"To get medically necessary state healthcare in Germany, UK travelers need a GHIC or an EHIC","source":{"url":"https://www.gov.uk/foreign-travel-advice/germany/health","host":"gov.uk","quote":"To get medically necessary state healthcare in Germany, you need a Global Health Insurance Card ( GHIC ) or a European Health Insurance Card ( EHIC ).","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V6","item":"emergency_number","audience":"all","volatile":false,"text":"Dial 112 and ask for an ambulance in Germany","source":{"url":"https://www.gov.uk/foreign-travel-advice/germany/health","host":"gov.uk","quote":"Dial 112 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["austria","china","israel","italy","lithuania","republic-of-korea","spain","thailand","turkey","united-kingdom","united-states"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.5,"count":57,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>CAR T-cell therapy in Germany typically costs from _op_800_price_from_ to _op_800_price_to_. The total price depends on the chosen medical product, clinic tier, and required hospital stay. In the US, similar procedures cost around _price_compare_US_average_ on average. Patients save around _price_percent_discount_% compared to US rates. The cost generally includes cell collection, engineering, and specialized monitoring.</p>\n\n<ul>\n<li><strong>Therapy type:</strong> Prices vary based on specific products like Kymriah or Yescarta.</li>\n<li><strong>Hospital facilities:</strong> Major university hospitals in Frankfurt and Heidelberg may have premium pricing structures.</li>\n<li><strong>Medical monitoring:</strong> Intensive care stays for managing cytokine release syndrome increase the total budget.</li>\n<li><strong>Diagnostic services:</strong> Pre-treatment apheresis and conditioning chemotherapy typically add to the final medical bill.</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight:</strong> Choosing a leading research center provides access to the latest oncology innovations. Nordwest Clinic in Frankfurt is recognized among the best hospitals by Newsweek magazine. It integrates five research institutes directly into patient care. This clinical depth ensures expert management of complex cell therapies. Their focus on targeted therapy vaccines reflects a high specialization in advanced cancer treatments. Focusing on such accredited centers ensures top-tier safety standards for this sophisticated procedure.</p>","faq":[{"q":"What is CAR T-cell therapy and which cancers is it approved for in Germany?","a":"<p>CAR T-cell therapy is a personalized immunotherapy where doctors genetically modify a patient's own T-cells to identify and destroy cancer. In Germany, this therapy is approved for specific blood cancers including leukemia, various lymphomas, and multiple myeloma when standard treatments have failed.</p> <ul> <li><strong>Approved leukemia:</strong> Treats B-cell acute lymphoblastic leukemia (ALL) in children and young adults.</li> <li><strong>Lymphoma indications:</strong> Approved for diffuse large B-cell, mantle cell, and follicular lymphoma types.</li> <li><strong>Myeloma treatment:</strong> Used for multiple myeloma when plasma cells become cancerous and resist chemotherapy.</li> <li><strong>Medical oversight:</strong> Administered in specialized centers like Nordwest Clinic in Frankfurt am Main.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Germany provides a significant financial advantage for this advanced treatment. While the procedure averages _price_compare_US_average_ in the US, patients in Germany can access the same protocols for _op_800_price_from_ to _op_800_price_to_. This represents a saving of approximately _price_percent_discount_% without compromising on innovative technology or safety standards.</p> <p><strong>Patient Consensus:</strong> Many acknowledge the treatment is physically intense because of side effects like high fever. The monitoring period after infusion is often more challenging for families than the procedure itself.</p>"},{"q":"Which hospitals in Germany are certified to deliver CAR T-cell therapy?","a":"<p>Certified hospitals in Germany for CAR T-cell therapy include Heidelberg University Hospital, University Hospital Frankfurt, and Nordwest Clinic Frankfurt. These academic centers maintain specialized certifications for treating aggressive blood cancers. Many provide manufacturer-linked logistics, apheresis capabilities, and intensive monitoring units essential for safe cellular immunotherapy delivery.</p> <ul> <li><strong>Heidelberg University:</strong> First German center certified for CAR T-cell therapy with in-house cell production capabilities.</li> <li><strong>Nordwest Clinic Frankfurt:</strong> ESMO-certified oncology center featuring five research institutes and specialized cancer development centers.</li> <li><strong>University Hospital Cologne:</strong> Leading certified facility expert in coordinating apheresis-to-infusion pathways for lymphoma patients.</li> <li><strong>Würzburg and Ulm:</strong> Recognized academic hospitals providing intensive care backup for complex immunotherapy monitoring.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Germany is a global leader, ranking 3rd in our network for oncology requests. Only a small fraction of its 82 clinics can offer CAR T-cell therapy. Nordwest Clinic is a standout. It treats 61,000 patients annually and holds the World's Best Hospitals 2021 honor. This volume ensures high safety standards for complex cellular therapies.</p> <p><strong>Patient Consensus:</strong> Finding a certified hospital is only step one. Patients emphasize that having a hematologist coordinate the referral is the critical move for securing a treatment slot.</p>"},{"q":"What are the main early- and late-phase side effects after CAR T-cell infusion?","a":"<p>Side effects from CAR T-cell therapy in Germany occur in two distinct stages. Early-phase effects include cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome within 28 days. Late-phase effects involve prolonged cytopenias, B-cell aplasia, and persistent immune suppression occurring months after infusion.</p> <ul> <li><strong>Cytokine release syndrome:</strong> Systemic inflammation causing high fevers, low blood pressure, and hypoxia within 48 hours.</li> <li><strong>Neurological toxicity (ICANS):</strong> Neurological symptoms like confusion, encephalopathy, motor weakness, and seizures shortly after infusion.</li> <li><strong>Prolonged cytopenias:</strong> Continued low white blood cell and platelet counts persisting beyond 1 month.</li> <li><strong>B-cell aplasia:</strong> Depletion of healthy B-cells leading to low antibody levels and infection risks.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German centers like Nordwest Clinic utilize intensive monitoring because side effects often appear after patients feel fine. While cytokine release syndrome is well-known, neurotoxicity can be subtle, starting with simple word-finding problems or tremors. Leading German hospitals integrate specialized neurology teams into oncology units to manage these specific transitions safely.</p> <p><strong>Patient Consensus:</strong> Many patients find the profound fatigue and `brain fog` more persistent than clinical descriptions suggest. Caregivers should watch for any subtle changes in speech or alertness during the first few weeks home.</p>"},{"q":"How is the recovery phase managed to limit infection-related complications?","a":"<p>Recovery involves intensive monitoring within specialized German oncology centers to prevent infections during the neutropenic phase. Clinicians use prophylactic medications, strict reverse isolation, and frequent blood counts to manage immunity. Advanced facilities like Nordwest Clinic utilize integrated research to identify and treat complications like cytokine release syndrome early.</p> <ul> <li><strong>Prophylactic medication:</strong> Patients receive mandatory antibiotic, antiviral, and antifungal drugs during vulnerable periods.</li> <li><strong>Strict isolation:</strong> Patients must avoid crowds, public transit, and sick contacts post-infusion.</li> <li><strong>Infection monitoring:</strong> Immediate hospitalization and IV antibiotics are required for any post-treatment fever.</li> <li><strong>Immune support:</strong> Doctors may administer intravenous immunoglobulin if antibody levels remain critically low.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German clinics like Nordwest Clinic bridge the gap between research and care by housing specialized institutes onsite. This integration means patients benefit from real-time immune reconstitution monitoring that dictates exactly when safety precautions can be relaxed. This data-driven approach ensures safety isn't based on symptoms alone but on verified cellular recovery.</p> <p><strong>Patient Consensus:</strong> Many patients emphasize the need for constant vigilance, including frequent temperature checks and strict masking. They recommend keeping a thermometer ready at all times and knowing exactly which symptoms require an urgent hospital return.</p>"},{"q":"How does a patient access CAR T-cell therapy clinics in Germany and book a consultation?","a":"<p>Patients access CAR T-cell therapy in Germany through a referral-based intake process at specialized academic centers. Most cases require an initial review by a hematologist or oncologist to verify eligibility based on treatment history and specific blood cancer subtypes before booking an expert consultation.</p> <ul> <li><strong>Referral requirement:</strong> Local oncologists must refer patients to university hospitals for advanced cellular therapy.</li> <li><strong>Clinical centers:</strong> Treatment occurs at elite institutions like Nordwest Clinic or major university hospitals.</li> <li><strong>Documentation:</strong> Centers require complete pathology, imaging reports, and treatment timelines for the first review.</li> <li><strong>Insurance clearance:</strong> Hospital teams assist with authorization due to the therapy high complexity and regulations.</li> <li><strong>Specialized intake:</strong> Booking is a multi-step case review rather than a standard outpatient appointment.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Germany ranks among the top 3 global destinations for complex hematology due to its centralized academic hospital structure. While smaller clinics exist, our data shows patients find better success at research-heavy institutions like Nordwest Clinic. These centers utilize specialized teams to manage the weeks-long transition from initial referral to the leukapheresis cell-collection phase.</p> <p><strong>Patient Consensus:</strong> Accessing these centers is best managed by preparing a exhaustive medical file to prevent delays. Many patients emphasize that having an oncologist advocate for the referral speeds up the eligibility screening process.</p>"},{"q":"Which hospitals in Germany are top-rated for neurosurgery?","a":"<p>Germany features some of the worlds most prestigious neurosurgery departments, led by Charité – Universitätsmedizin Berlin and University Hospital Heidelberg. These centers excel in treating complex brain tumors and cerebrovascular disorders. They utilize advanced technologies like intraoperative MRI and computer-assisted neuronavigation to maximize procedural success.</p> <ul> <li><strong>Charité Berlin:</strong> Performs 5,000+ surgeries annually. Led by renowned neurosurgeon Dr. Peter Vajkoczy.</li> <li><strong>Medical Center Solingen:</strong> Dr. Ralf Buhl has performed 4,000+ procedures, including minimally invasive spine surgery.</li> <li><strong>Asklepios Nord Clinic:</strong> Features Germany's only two-sided intraoperative MRI for real-time surgical precision during tumor removals.</li> <li><strong>Nordwest Clinic:</strong> Recognized by Newsweek as a leading hospital for innovations in 3D ultrasound technology.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Data shows that choosing high-volume centers often leads to more conservative treatment recommendations. At Medical Center Solingen, which treats 60,000+ patients yearly, surgeons frequently suggest physiotherapy over immediate surgery if risks appear high. This volume-based expertise ensures patients only undergo operations when statistically necessary for recovery.</p> <p><strong>Patient Consensus:</strong> Patients note that German specialists are very cautious and will explain all risks before proceeding. Many emphasize the comfort of modern facilities, though some mention that having a translator is helpful for navigating administrative paperwork.</p>"},{"q":"What are the reported success rates for high-complexity neurosurgery in Germany?","a":"<p>High-complexity neurosurgery in Germany demonstrates exceptional safety. Spinal fusions reach a 99% success rate. Primary brain tumor resections maintain a 97% survival rate. Functional independence is high. Over 82% of patients discharge directly home after treatment. German centers prioritize preserving neurological function using advanced mapping.</p> <ul> <li><strong>Tumor resection:</strong> Surgeons achieve gross total resection in 87.2% of brain metastasis cases.</li> <li><strong>Vascular success:</strong> Unruptured aneurysm treatments show a 98.7% survival rate in German hospitals.</li> <li><strong>Neurological improvement:</strong> Nearly 43% of patients see functional score gains after complex resections.</li> <li><strong>Surgical safety:</strong> Spinal procedures maintain a 98–99% survival rate across major surgical centers.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> High-volume surgeons like Dr. Uwe Kehler at Asklepios Altona Clinic perform 2,000+ operations annually. Data shows these experts maintain success rates up to 90% for the most complex cerebral tumors. Choosing a specialist with 4,000+ personal surgeries, such as Dr. Ralf Buhl, ensures technical precision gathered over decades of practice.</p> <p><strong>Patient Consensus:</strong> Patients note that German surgeons often prioritize physical function over aggressive tumor removal. It is important to write down all questions in advance to make the most of short consultations with busy professors.</p>"},{"q":"What advanced technologies are routinely available in German neurosurgical clinics?","a":"<p>German neurosurgical clinics routinely integrate high-precision digital tools and real-time imaging into surgical practice. Core technologies include computer-assisted neuronavigation for brain and spinal procedures. Facilities like Asklepios Nord Clinic use intraoperative MRI to verify tumor removal in real time. These systems provide a 3D GPS for surgeons.</p> <ul> <li><strong>Neuronavigation:</strong> Provides 3D visualization and real-time instrument tracking for sub-millimeter surgical precision.</li> <li><strong>Intraoperative imaging:</strong> Systems like iMRI and O-arm CT allow immediate verification of successful resection.</li> <li><strong>Neuromonitoring:</strong> Tracks motor and sensory functions during surgery to protect the nervous system.</li> <li><strong>Fluorescence diagnostics:</strong> Uses 5-ALA dye to illuminate tumor borders for more complete removal.</li> <li><strong>Robotic assistance:</strong> Systems like Da Vinci enhance dexterity for complex minimally invasive procedures.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> High-volume centers like Charité – Universitätsmedizin Berlin perform 4,000+ neurosurgeries annually, creating a data-rich environment for refining robotic protocols. Medical Center in Solingen offers specialized packages for herniated disc surgery including preoperative diagnostics. This volume allows German clinics to negotiate better rates for consumables, keeping advanced tech accessible.</p> <p><strong>Patient Consensus:</strong> Patients note that modern German clinics significantly reduce recovery times compared to older surgical methods. Many describe the experience as less painful due to smaller incisions and highly competent staff who explain every technical risk clearly.</p>"},{"q":"What specialist training do practicing neurosurgeons in Germany complete?","a":"<p>Neurosurgeons in Germany must complete 6 years of specialized residency training after medical school. This structured program includes intensive care, clinical practice, and a mandatory surgical log. Candidates then pass a state board exam to earn the title Facharzt für Neurochirurgie.</p> <ul> <li><strong>Clinical residency:</strong> Requires 48 to 72 months of dedicated neurosurgical practice.</li> <li><strong>Intensive care:</strong> Includes mandatory 6-month rotation in a neurosurgical intensive care unit.</li> <li><strong>Surgical log:</strong> Surgeons document hundreds of procedures, including craniotomies and spinal surgeries.</li> <li><strong>Board examination:</strong> Candidates must pass a state-administered oral and practical medical assessment.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German neurosurgery training emphasizes high-volume surgical experience. For example, Dr. Ralf Buhl at Medical Center in Solingen has performed 4,000+ surgeries. Dr. Jürgen Kiwit at Meoclinic Hospital brings 25+ years of expertise. This rigorous system ensures that specialists at major centers manage complex cases with proven precision.</p> <p><strong>Patient Consensus:</strong> Patients feel confident knowing their doctors underwent years of strict, state-monitored training. Many note that the detailed documentation of a surgeon's past procedures provides significant peace of mind before surgery.</p>"},{"q":"What language and licensure requirements apply to international surgeons aiming to train or observe neurosurgery cases in Germany?","a":"<p>International neurosurgeons must meet strict language and licensure standards to train or observe in Germany. Training requires a full medical license or temporary permit. Observers need hospital-specific approval. Both paths demand high-level German proficiency to participate in clinical discussions and follow complex surgical protocols safely.</p> <ul> <li><strong>Language proficiency:</strong> General German B2 and medical C1 (Fachsprachprüfung) are mandatory for clinical training.</li> <li><strong>Clinical licensure:</strong> Surgeons need Approbation for permanent practice or Berufserlaubnis for temporary supervised training.</li> <li><strong>Observation status:</strong> A Hospitation allows observing surgeries without medical responsibility or a formal license.</li> <li><strong>Credential evaluation:</strong> Non-EU graduates often face a 3–6 month process to verify their medical degrees.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German clinics with high patient volumes, like Nordwest Clinic or Asklepios Nord, often prioritize candidates who have already secured their preliminary document evaluation. Our data shows that professors like Dr. Uwe Kehler and Dr. Paul Kremer manage thousands of cases annually. Demonstrating German B2 level early can bypass many bureaucratic delays in these busy departments.</p> <p><strong>Patient Consensus:</strong> Patients note that the language barrier is significant. They emphasize that while some international staff help, having a translator or a German-speaking doctor is vital for clear communication.</p>"},{"q":"Does Germany have enough neurosurgeons to handle both domestic and international patient volumes?","a":"<p>Germany maintains the highest density of neurosurgeons in Europe with 2.94 specialists per 100,000 residents. This robust workforce easily manages international volumes through 184 dedicated departments. Key facilities like Charite Berlin perform 4,000+ surgeries annually. High specialist availability ensures additional capacity for complex global cases.</p> <ul> <li><strong>Specialist density:</strong> Germany has 2.94 neurosurgeons per 100,000 people, doubling the European average.</li> <li><strong>Clinical infrastructure:</strong> Over 182 dedicated neurosurgical departments provide widespread geographic access across Germany.</li> <li><strong>Surgical expertise:</strong> Prof. Dr. Peter Vajkoczy at Charite Berlin leads over 4,000 annual procedures.</li> <li><strong>Advanced technology:</strong> Facilities like Asklepios Nord Clinic utilize intraoperative MRI and computerized neuronavigation.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While Germany has high specialist numbers, top-tier professors like Dr. Ralf Buhl or Dr. Uwe Kehler are often concentrated in major hubs like Hamburg or Solingen. Our data shows these high-volume centers actually offer faster access for international patients than smaller clinics. Large academic hospitals maintain dedicated tracks for complex cases, effectively bypassing local capacity bottlenecks found in rural areas.</p> <p><strong>Patient Consensus:</strong> Patients often note that while surgeons are highly professional, clear communication about reports can sometimes take time. One patient mentioned that recovery periods in German clinics are now much shorter and less painful than in previous decades.</p>"}],"h2":[{"text":"Qual é o Custo de Terapia com células T CAR em Alemanha? Descubra Agora","kind":"content"},{"text":"Seus Benefícios e Garantias com a Bookimed","kind":"content"},{"text":"Seu assistente Bookimed pessoal","kind":"content"},{"text":"Descubra as Melhores Clínicas de Terapia com células T CAR em Alemanha: 2 opções Verificadas e Preços","kind":"content"},{"text":"Visão geral de Terapia com células T CAR em Alemanha","kind":"content"},{"text":"Avaliações sobre Bookimed: descubra percepções de pacientes","kind":"content"},{"text":"Compartilhar este conteúdo","kind":"content"},{"text":"Histórias em vídeo de pacientes da Bookimed","kind":"content"},{"text":"Tudo o que Precisar Saber sobre Terapia com células T CAR em Alemanha","kind":"content"},{"text":"O que é a Terapia com Células CAR T na Alemanha?","kind":"content"},{"text":"Quais são os Tratamentos Oncológicos Disponíveis?","kind":"content"},{"text":"Como a Terapia com Células CAR T se Compara a Outros Tratamentos?","kind":"content"},{"text":"Quem é Candidato à Terapia com Células CAR T na Alemanha?","kind":"content"},{"text":"Como é Realizada a Terapia com Células CAR T?","kind":"content"},{"text":"Quanto Tempo Leva para se Recuperar?","kind":"content"},{"text":"Quais são os Riscos e Complicações?","kind":"content"},{"text":"Resultados: Quando Esperar um Efeito?","kind":"content"},{"text":"Por que Escolher a Terapia com Células CAR T na Alemanha?","kind":"content"},{"text":"O que Devo Saber Antes de Viajar para a Alemanha?","kind":"content"},{"text":"Quanto Custa a Terapia com Células CAR T na Alemanha?","kind":"content"},{"text":"O que Está Incluído nos Pacotes de Terapia com Células CAR T na Alemanha?","kind":"content"},{"text":"Referências","kind":"content"},{"text":"FAQ sobre Terapia com células T CAR em Alemanha","kind":"content"},{"text":"Obtenha uma consulta gratuita","kind":"content"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}